菲利华 reported revenue of ¥1.31B for the period ended 2026-06-30, +44.1% year on year. Net income was ¥0.31B, a 23.6% net margin on a 50.1% gross margin. The largest revenue line is 石英玻璃材料 at 56% of the total. Free cash flow for the period was ¥-0.11B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.31B | +44.1% |
| Gross profit | ¥0.66B | — |
| Operating income | ¥0.37B | — |
| Net income | ¥0.31B | +47.8% |
| Gross margin | 50.1% | Net margin 23.6% |
| Revenue Q/Q | +10.4% | — |
| Segment | Revenue | Share |
|---|---|---|
| 石英玻璃材料 | ¥0.74B | 56.5% |
| 石英玻璃制品 | ¥0.56B | 42.6% |
| 其他(补充) | ¥0.01B | 1.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.65B | 49.9% |
| R&D | ¥0.16B | 12.3% |
| SG&A | ¥0.12B | 9.5% |
| Tax & other | ¥0.06B | 4.4% |
| Item | Amount |
|---|---|
| Total assets | ¥8.17B |
| Total liabilities | ¥1.71B |
| Shareholders' equity | ¥6.46B |
| Equity / assets | 79.0% |
| Operating cash flow | ¥0.12B |
| Capital expenditure | ¥0.22B |
| Free cash flow | ¥-0.11B |
| Cash conversion (OCF / net income) | 44% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
ST迪瑞 ・ 天和防务 ・ 飞凯材料 ・ 天利科技 ・ 劲拓股份 ・ 花园生物 ・ 宝色股份 ・ 汉宇集团 ・ 博济医药 ・ 科隆股份 ・ 九强生物 ・ 凯发电气
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies